Xylem Inc. to Post FY2017 Earnings of $2.25 Per Share, Oppenheimer Holdings Forecasts (XYL)
Xylem Inc. (NYSE:XYL) – Analysts at Oppenheimer Holdings lowered their FY2017 earnings estimates for Xylem in a report released on Tuesday. Oppenheimer Holdings analyst J. Giannakouros now expects that the brokerage will earn $2.25 per share for the year, down from their prior forecast of $2.35. Oppenheimer Holdings currently has a “Outperform” rating and a $56.00 target price on the stock. Oppenheimer Holdings also issued estimates for Xylem’s FY2018 earnings at $2.65 EPS.
Xylem (NYSE:XYL) last issued its earnings results on Tuesday, November 1st. The company reported $0.54 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.53 by $0.01. The firm had revenue of $897 million for the quarter, compared to analyst estimates of $913.53 million. Xylem had a return on equity of 16.38% and a net margin of 8.83%. The business’s revenue was down .6% on a year-over-year basis. During the same period in the previous year, the company posted $0.49 earnings per share.
Several other analysts also recently weighed in on the company. Zacks Investment Research downgraded Xylem from a “hold” rating to a “sell” rating in a research note on Thursday. RBC Capital Markets restated an “outperform” rating and issued a $58.00 price target on shares of Xylem in a research note on Wednesday, December 28th. Boenning Scattergood downgraded Xylem from an “outperform” rating to a “neutral” rating in a research note on Monday, November 28th. Northcoast Research began coverage on Xylem in a research note on Thursday, November 17th. They issued a “buy” rating on the stock. Finally, Stifel Nicolaus upped their price target on Xylem from $47.00 to $48.00 and gave the stock a “hold” rating in a research note on Wednesday, November 2nd. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have given a buy rating to the company’s stock. Xylem currently has a consensus rating of “Hold” and an average price target of $47.54.
Shares of Xylem (NYSE:XYL) traded up 0.95% during mid-day trading on Thursday, hitting $48.76. The company’s stock had a trading volume of 2,811,321 shares. Xylem has a 52-week low of $31.67 and a 52-week high of $54.99. The company has a market cap of $8.75 billion, a price-to-earnings ratio of 27.06 and a beta of 1.18. The stock’s 50 day moving average price is $50.66 and its 200 day moving average price is $49.70.
A number of institutional investors have recently made changes to their positions in the company. Dempze Nancy E boosted its position in shares of Xylem by 0.3% in the second quarter. Dempze Nancy E now owns 16,760 shares of the company’s stock worth $748,000 after buying an additional 50 shares in the last quarter. Sanders Morris Harris Inc. boosted its stake in Xylem by 1.3% in the second quarter. Sanders Morris Harris Inc. now owns 6,410 shares of the company’s stock worth $286,000 after buying an additional 85 shares in the last quarter. National Asset Management Inc. boosted its stake in Xylem by 1.4% in the third quarter. National Asset Management Inc. now owns 7,002 shares of the company’s stock worth $368,000 after buying an additional 100 shares in the last quarter. Notis McConarty Edward boosted its stake in Xylem by 0.6% in the third quarter. Notis McConarty Edward now owns 17,455 shares of the company’s stock worth $916,000 after buying an additional 100 shares in the last quarter. Finally, Janney Montgomery Scott LLC boosted its stake in Xylem by 0.3% in the second quarter. Janney Montgomery Scott LLC now owns 38,127 shares of the company’s stock worth $1,392,000 after buying an additional 126 shares in the last quarter. 86.09% of the stock is currently owned by institutional investors.
In related news, SVP Claudia S. Toussaint sold 5,300 shares of the firm’s stock in a transaction on Friday, November 4th. The stock was sold at an average price of $47.27, for a total value of $250,531.00. Following the transaction, the senior vice president now directly owns 44,033 shares of the company’s stock, valued at approximately $2,081,439.91. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.77% of the stock is owned by corporate insiders.
Xylem Company Profile
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.